These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35258839)

  • 1. A Randomized, Open-Label, Single-Dose Study to Assess Safety and Systemic Exposure of Triamcinolone Acetonide Extended-Release in Patients With Hip Osteoarthritis.
    Kivitz A; Mehra P; Hanson P; Kwong L; Cinar A; Lufkin J; Kelley S
    Rheumatol Ther; 2022 Apr; 9(2):679-691. PubMed ID: 35258839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open-Label, Randomized Study.
    Hanson P; Kivitz A; Mehra P; Kwong L; Cinar A; Lufkin J; Kelley SD
    Drugs R D; 2021 Sep; 21(3):285-293. PubMed ID: 34350546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, phase IIa study to assess the systemic exposure of triamcinolone acetonide following injection of extended-release triamcinolone acetonide or traditional triamcinolone acetonide into both knees of patients with bilateral knee osteoarthritis.
    Kivitz A; Kwong L; Shlotzhauer T; Lufkin J; Cinar A; Kelley S
    Ther Adv Musculoskelet Dis; 2019; 11():1759720X19881309. PubMed ID: 31662801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA).
    Kraus VB; Conaghan PG; Aazami HA; Mehra P; Kivitz AJ; Lufkin J; Hauben J; Johnson JR; Bodick N
    Osteoarthritis Cartilage; 2018 Jan; 26(1):34-42. PubMed ID: 29024802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Treatment Effect of Triamcinolone Acetonide Extended-Release in Patients with Concordant Baseline Pain Scores on the Average Daily Pain and Western Ontario and McMaster Universities Osteoarthritis Index Pain Scales.
    Ross E; Katz NP; Conaghan PG; Kivitz A; Turk DC; Spitzer AI; Jones DG; Lanier RK; Cinar A; Lufkin J; Kelley SD
    Pain Ther; 2022 Mar; 11(1):289-302. PubMed ID: 34791634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study.
    Russell SJ; Sala R; Conaghan PG; Habib G; Vo Q; Manning R; Kivitz A; Davis Y; Lufkin J; Johnson JR; Kelley S; Bodick N
    Rheumatology (Oxford); 2018 Dec; 57(12):2235-2241. PubMed ID: 30203101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis.
    Langworthy MJ; Conaghan PG; Ruane JJ; Kivitz AJ; Lufkin J; Cinar A; Kelley SD
    Adv Ther; 2019 Jun; 36(6):1398-1411. PubMed ID: 30968336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local Effects Following Single and Repeat Intra-Articular Injections of Triamcinolone Acetonide Extended-Release: Results from Three Nonclinical Toxicity Studies in Dogs.
    Bodick N; Williamson T; Strand V; Senter B; Kelley S; Boyce R; Lightfoot-Dunn R
    Rheumatol Ther; 2018 Dec; 5(2):475-498. PubMed ID: 30203389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study.
    Conaghan PG; Hunter DJ; Cohen SB; Kraus VB; Berenbaum F; Lieberman JR; Jones DG; Spitzer AI; Jevsevar DS; Katz NP; Burgess DJ; Lufkin J; Johnson JR; Bodick N;
    J Bone Joint Surg Am; 2018 Apr; 100(8):666-677. PubMed ID: 29664853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescue Analgesic Medication Use by Patients Treated with Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinical Trials.
    Kivitz AJ; Conaghan PG; Cinar A; Lufkin J; Kelley SD
    Pain Ther; 2019 Dec; 8(2):271-280. PubMed ID: 31066021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, Tolerability, and Pharmacokinetics of Same-Knee Intra-Articular Injection of Corticosteroid and Lorecivivint Within 7 Days: An Open-Label, Randomized, Parallel-Arm Study.
    Fineman MS; McAlindon TE; Lattermann C; Swearingen CJ; Kennedy S; Lopez VA; Simsek I; Tambiah JRS; Yazici Y
    Rheumatol Ther; 2023 Dec; 10(6):1741-1752. PubMed ID: 37902943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Repeat Administration of Triamcinolone Acetonide Extended-release in Osteoarthritis of the Knee: A Phase 3b, Open-label Study.
    Spitzer AI; Richmond JC; Kraus VB; Gomoll A; Jones DG; Huffman KM; Peterfy C; Cinar A; Lufkin J; Kelley SD
    Rheumatol Ther; 2019 Mar; 6(1):109-124. PubMed ID: 30741382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triamcinolone Acetonide Extended-Release: A Review in Osteoarthritis Pain of the Knee.
    Paik J; Duggan ST; Keam SJ
    Drugs; 2019 Mar; 79(4):455-462. PubMed ID: 30847805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-Release Versus Immediate-Release Triamcinolone Acetonide in Patients Who Have Knee Osteoarthritis and Type 2 Diabetes Mellitus.
    Spitzer AI; Rodbard HW; Iqbal SU; Nakazawa M; DiGiorgi M; Winston R
    J Arthroplasty; 2024 Sep; 39(9S2):S218-S223.e1. PubMed ID: 38815874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical and Chemical Compatibility of Extended-Release Triamcinolone Acetonide (TA-ER) with Common Local Anesthetics.
    Jackson JD; Cotton L; Turkington M; Leblanc D; Kelley S
    Adv Ther; 2019 Mar; 36(3):652-661. PubMed ID: 30706409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability of Biphasic-Release Hydrocodone Bitartrate/Acetaminophen Tablets (MNK-155): A Phase III, Multicenter, Open-Label Study in Patients With Osteoarthritis or Chronic Low Back Pain.
    Zheng Y; Kostenbader K; Barrett T; Hisaw E; Giuliani MJ; Chen Y; Young JL
    Clin Ther; 2015 Jun; 37(6):1235-47. PubMed ID: 25913923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial.
    Bodick N; Lufkin J; Willwerth C; Kumar A; Bolognese J; Schoonmaker C; Ballal R; Hunter D; Clayman M
    J Bone Joint Surg Am; 2015 Jun; 97(11):877-88. PubMed ID: 26041848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and performance of Hydros and Hydros-TA for knee osteoarthritis: a prospective, multicenter, randomized, double-blind feasibility trial.
    Petrella RJ; Emans PJ; Alleyne J; Dellaert F; Gill DP; Maroney M
    BMC Musculoskelet Disord; 2015 Mar; 16():57. PubMed ID: 25887932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Pain and Function With Triamcinolone Acetonide Extended-Release and Cryoneurolysis for Knee Osteoarthritis: Use of a New Real-World Registry.
    Mont MA; Lin JH; Spitzer AI; Dasa V; Rivadeneyra A; Rogenmoser D; Concoff AL; Ng MK; DiGiorgi M; DySart S; Urban J; Mihalko WM
    J Arthroplasty; 2024 Jun; ():. PubMed ID: 38936436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of triamcinolone acetonide following intramuscular and intra-articular administration to exercised Thoroughbred horses.
    Knych HK; Vidal MA; Casbeer HC; McKemie DS
    Equine Vet J; 2013 Nov; 45(6):715-20. PubMed ID: 23574452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.